A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)
Shohreh Honarbakhsh(Barts Health NHS Trust), Pier D. Lambiase(University College London), Sarju Mehta(Addenbrooke's Hospital), Wei Yao Lim(Barts Health NHS Trust), Francisco Darrieux(Universidade de São Paulo), David Prieto‐Merino(London School of Hygiene & Tropical Medicine), Diogo Cavaco(Hospital de Santa Cruz), Juan R. Gimeno(Hospital Universitario Virgen de la Arrixaca), Ardalan Sharifzadehgan(Inserm), Lia Crotti(IRCCS Istituto Auxologico Italiano), Philippe Chevalier(Inserm), Victor Waldmann(Hôpital Necker-Enfants Malades), Javier Lacunza(Hospital Universitario Virgen de la Arrixaca), Patrick M. Heck(Papworth Hospital NHS Foundation Trust), Christian Veltmann(Medizinische Hochschule Hannover), Luciana Sacilotto(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Pedro Adragão(Hospital de Santa Cruz), Richard J. Schilling(British Heart Foundation), Alessandro Vicentini(Policlinico San Matteo Fondazione), João de Sousa(University of Lisbon), Silvia Castelletti(University of Coimbra), Claire Kirkby(Barts Health NHS Trust), Nuno Cortez‐Dias(University of Lisbon), Carmen Muñoz‐Esparza(Hospital Universitario Virgen de la Arrixaca), Ziad Khoueiry(Université de Perpignan), Tardu Özkartal(Epatocentro Ticino), Maurício Scanavacca(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Natália António(University of Coimbra), Rui Providência(Rutgers, The State University of New Jersey), Andrea Demarchi(Policlinico San Matteo Fondazione), Adam Graham(Barts Health NHS Trust), Jorge García-Hernández(Farr Institute), Serge Boveda(Clinique Pasteur), Peter Schwartz(IRCCS Istituto Auxologico Italiano), Ross J. Hunter(Barts Health NHS Trust), Pedro Silverio Antonio(University of Lisbon), Mario João Sousa(Clinique Pasteur), Luís Elvas(University of Coimbra), Francisco Morosco Costa(Hospital de Santa Cruz), Claire A Martin(Papworth Hospital NHS Foundation Trust), Giulio Conte(Epatocentro Ticino), Martin Löwe(Barts Health NHS Trust), Zeynab Jebberi(Clinique Pasteur), Éloi Marijon(Hôpital Européen Georges-Pompidou), Angelo Auricchio(Epatocentro Ticino), Bénédicte Ankou(Université Claude Bernard Lyon 1)
Cited by 94
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811